AHA 22: Dr Paul Wang (Cardiac Arrhythmia Service at Palo Alto, Stanford, CA, US) joins us remotely to discuss the findings of the ENHANCE-AF trial, originally presented at the American Heart Association’s 2022 Scientific Sessions.
ENHANCE AF aimed to evaluate whether a shared-decision-making pathway tool would reduce the risk of stroke as a result of atrial fibrillation when compared to standard care. Over 1000 patients were involved in the trial.
What was the reasoning behind this study?
What was the patient population and study design?
What were the key findings?
Based on these findings, how should this study impact practice?
What further study is still needed?
Recorded Remotely from Stanford, 2022.
Interviewer: Jordan Rance
Videography: Dan Brent